What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2020-08-14 compared with 2020-05-19 · 8 added, 82 removed, 20 unchanged (82% of the section changed)

OTHER INFORMATION

Securities Purchase Agreements

From April 1, 2020 through

April 30, 2020, we entered into securities purchase agreements (the “Purchase Agreements”) with nine (9) accredited

investors whereby such investors purchased an aggregate of 6,243,750 shares of our common stock at a price of $0.16 per share, resulting

in the aggregate of $999,000 of proceeds to the Company (the “April Common Stock Offering”).

On May 12, 2020, we

entered into a Purchase Agreement with one (1) accredited investor whereby such investor purchased an aggregate of 1,470,588 shares of

our common stock at $0.17 per share, resulting in aggregate gross proceeds to the Company of $250,000 (the “May Common Stock

Offering”).

Both the April Common

Stock Offering and May Common Stock Offering were conducted in reliance upon an exemption from securities registration afforded

by the provisions of Section 4(a)(2), as promulgated by the United States Securities and Exchange Commission under the Securities

Act of 1933, as amended.

The foregoing description

of the Purchase Agreement is qualified in its entirety by reference to the Purchase Agreement, the form of which is filed as an

exhibit to this quarterly report on Form 10-Q.

Auxo Technology Labs

On April 14, 2020,

we entered into a consulting agreement (the “Auxo Agreement”) with Auxo Technology Labs, Inc.

(“Auxo”) whereby Auxo shall serve the Company in the capacity of consultant and assist us with designing and

developing software related to Auxo’s telehealth platform for use by the Company.

Pursuant to the terms of the Auxo

Agreement, we will acquire the exclusive rights to Auxo’s telehealth platform (the “Auxo Platform”) for the

North American direct to consumer pharmaceutical market.

As consideration for

entering into the Auxo Agreement, we issued to Auxo an option to purchase up to 500,000 shares of our common stock at an exercise

price of $0.23 and vesting upon the occurrence of the earlier of (i) two (2) years from the date of issuance or (ii) the Company’s

common stock trading at price of $1.00 per share.

Additionally, we agreed to pay Auxo an aggregate of $150,000, with $55,000 paid

on execution of the Auxo Agreement and the remaining $95,000 to be paid on a monthly basis in the amount of $2,500 per month for

thirty-eight (38) months.

The foregoing description

of the Auxo Agreement Auxo is qualified in its entirety by reference to the Auxo Agreement, which is filed as an exhibit to this

quarterly report on Form 10-Q.

Schreiber Consulting Agreement

Effective March 1, 2020, the

Company entered into a consulting services agreement by and between the Company and JLS Ventures, LLC (the “JLS Consulting

Agreement”), pursuant to which Justin Schreiber, as President of JLS Ventures, LLC, would serve as the Company’s Chief

Executive Officer and Chairman of the Board of Directors.

The JLS Consulting Agreement provides that Mr.

Schreiber will receive

a monthly cash payment of $15,000.

The JLS Consulting Agreement has an initial term of 12 months beginning January 1, 2020 and

is renewable for additional twelve-month periods upon the mutual agreement of the Company and JLS Ventures, LLC.

Alvarez Amendment to Employment Agreement

On April 1, 2020, the

Company entered into the second amendment to employment agreement by and between the Company and Nicholas Alvarez (the “Alvarez

Employment Agreement Amendment”).

The Alvarez Employment Agreement Amendment provides that Mr.

Alvarez will serve as the

Company’s Chief Acquisition Officer and will receive an annual salary of $140,000 (the “Alvarez Salary”) and

be eligible for an annual cash bonus of up to 100% of the Alvarez Salary payable at the discretion of the Board.

Galluppi Amendment to Employment Agreement

On April 1, 2020, the

Company entered into the first amendment to employment agreement by and between the Company and Stefan Galluppi (the “Galluppi

Employment Agreement Amendment”).

The Galluppi Employment Agreement Amendment provides that Mr.

Galluppi will continue to

serve as the Company’s Chief Technology Officer and will receive an annual salary of $180,000 (the “Galluppi Salary”)

and will be eligible to receive an annual bonus of up to $100,000 payable at the discretion of the Board.

Blue Horizon Consulting Agreement

On May 1, 2020, the

Company entered into a consulting services agreement (the “Blue Horizon Agreement”) by and between the Company and

Blue Horizon Consulting, LLC (“Blue Horizon”).

Pursuant to the Blue Horizon Agreement, Blue Horizon will serve as

the Company’s Managing Director and will receive a monthly cash payment of $15,000.

The Blue Horizon Agreement has an initial

term of 12 months beginning January 1, 2020 and is renewable for additional twelve-month periods upon the mutual agreement of

the Company and Blue Horizon.

Period End Date

of Amendment to Certificate of Incorporation

Amendment by and between the Company and Mr.

Sean Fitzpatrick.

Agreement by and between the Company and Mr.

Nicholas Alvarez..

Date/Period End Date

Filed Herewith

Form of Convertible Redeemable Promissory Note

Alpha 2019 Note Repayment and Warrant Amendment

4 unchanged sentences

Consulting Agreement by and between the Company and Auxo Technology Labs.

Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.

Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.

Section 1350 Certification of Chief Executive Officer.

Section 1350 Certification of Chief Financial Officer.

13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.

13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.

1350 Certification of Chief Executive Officer.

1350 Certification of Chief Financial Officer.

Instance Document

4 unchanged sentences

Taxonomy Extension Presentation Linkbase Document

Indicates management contract or compensatory plan, contract or arrangement.

Filed herewith.

Furnished herewith.

In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report

6 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information